agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $513.44 million. The enterprise value is $265.12 million.
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 16.59 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 16.59M |
| Shares Outstanding | 16.59M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 2.12% |
| Owned by Institutions (%) | 103.77% |
| Float | 10.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| Forward PS | 0.09 |
| PB Ratio | 4.05 |
| P/TBV Ratio | 13.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.02 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -63.41 |
Financial Efficiency
Return on equity (ROE) is -135.64% and return on invested capital (ROIC) is -77.86%.
| Return on Equity (ROE) | -135.64% |
| Return on Assets (ROA) | -17.51% |
| Return on Invested Capital (ROIC) | -77.86% |
| Return on Capital Employed (ROCE) | -216.15% |
| Weighted Average Cost of Capital (WACC) | 6.61% |
| Revenue Per Employee | $6.93M |
| Profits Per Employee | -$457,181 |
| Employee Count | 856 |
| Asset Turnover | 3.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $1.25 million in taxes.
| Income Tax | 1.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.62% in the last 52 weeks. The beta is 0.33, so agilon health's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -77.62% |
| 50-Day Moving Average | 14.11 |
| 200-Day Moving Average | 24.28 |
| Relative Strength Index (RSI) | 81.48 |
| Average Volume (20 Days) | 341,067 |
Short Selling Information
The latest short interest is 1.36 million, so 8.18% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 983,659 |
| Short % of Shares Out | 8.18% |
| Short % of Float | 12.67% |
| Short Ratio (days to cover) | 7.00 |
Income Statement
In the last 12 months, agilon health had revenue of $5.93 billion and -$391.35 million in losses. Loss per share was -$23.63.
| Revenue | 5.93B |
| Gross Profit | -160.02M |
| Operating Income | -421.08M |
| Pretax Income | -404.10M |
| Net Income | -391.35M |
| EBITDA | -406.18M |
| EBIT | -421.08M |
| Loss Per Share | -$23.63 |
Full Income StatementBalance Sheet
The company has $285.14 million in cash and $36.82 million in debt, with a net cash position of $248.33 million or $14.96 per share.
| Cash & Cash Equivalents | 285.14M |
| Total Debt | 36.82M |
| Net Cash | 248.33M |
| Net Cash Per Share | $14.96 |
| Equity (Book Value) | 126.73M |
| Book Value Per Share | 7.64 |
| Working Capital | 20.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$105.76 million and capital expenditures -$13.24 million, giving a free cash flow of -$119.01 million.
| Operating Cash Flow | -105.76M |
| Capital Expenditures | -13.24M |
| Depreciation & Amortization | 14.89M |
| Net Borrowing | n/a |
| Free Cash Flow | -119.01M |
| FCF Per Share | -$7.17 |
Full Cash Flow StatementMargins
Gross margin is -2.70%, with operating and profit margins of -7.10% and -6.60%.
| Gross Margin | -2.70% |
| Operating Margin | -7.10% |
| Pretax Margin | -6.81% |
| Profit Margin | -6.60% |
| EBITDA Margin | -6.85% |
| EBIT Margin | -7.10% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.73% |
| Earnings Yield | -76.22% |
| FCF Yield | -23.18% |
Analyst Forecast
The average price target for agilon health is $55.68, which is 79.96% higher than the current price. The consensus rating is "Hold".
| Price Target | $55.68 |
| Price Target Difference | 79.96% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 5.66% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
agilon health has an Altman Z-Score of 1.89 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.89 |
| Piotroski F-Score | 3 |
